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  The major limitation to heart transplantation is the shortage of donor organs. In order to increase the cardiac do-
nor pool, it is important to maintain stable hemodynamics and closely monitor cardiac function in cadaveric organ 
donors or potent donors. Recently, management of a potential cardiac donor pool has focused on aggressive hemo-
dynamic management protocols and dobutamine stress echocardiography. In our case, management with low dose do-
butamine, glucose-insulin-potassium (GIK), and hormone therapy reversed heart failure following brain death and the 
heart was successfully transplanted. We suggest that aggressive hemodynamic management with low-dose dobut-
amine, GIK, and hormone therapy can result in the recruitment of more cadaveric hearts in marginal conditions.
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  The shortage of donor hearts for cardiac transplantation is 
exacerbated by the exclusion of those that exhibit reversible 
myocardial dysfunction induced by brain death.1-4) Clinical and 
laboratory data have described acute myocardial dysfunction 
after brain injury, which prevents heart donations from cadave-
ric organ donors. Recent report recommend hemodynamic and 
metabolic management should be performed before the organ is 
declined when donor left ventricular dysfunction is present.5,6) 
We report a case of a successfully transplanted heart after the 
reversal of heart failure following brain death, which was re-
versed using low dose dobutamine, GIK, and hormone.
CASE REPORT
  A 39-year-old previously healthy man presented to an emer-
gency department (ED) with loss of consciousness following a 
seizure. His medical history, obtained from his family, was 
unremarkable. There was no past history of trauma or neuro-
logic disease. Computed tomography revealed paraventricular 
hemorrhage from an arteriovenous malformation. An emergency 
hematoma drainage was performed, but brain stem death was 
suspected. The patient was transferred to our university hospi-
tal for organ donation. The patient was immediately admitted 
to the intensive care unit (ICU) via the ED.
  On arrival at the ICU, the patient presented with a blood 
pressure of 146/106 mmHg, heart rate of 125 bpm, and rectal 
temperature of 34.6oC. He was in a coma, with a Glasgow 
Coma Scale score of 3 with fixed, nonreactive pupils 5 mm in 
diameter bilaterally. Because he was not hypotensive, infusions 
of dopamine, epinephrine and dobutamine, which had been 
started at the previous hospital, were stopped. The concen-
tration of each drug was not well documented. Soon after, the 
patient became hypotensive, so we started a norepinephrine in-
fusion of 0.3μg/kg/min and vasopressin of 0.03 units/min. The 
dose of norepinephrine was reduced to 0.1μg/kg/min within 2 
hr after admission. A pulmonary artery catheter (PAC, Swan- 
Ganz CCOmbo CCO/SvO2TM, Edwards Lifesciences LLC, Ir-
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Fig. 1. M-mode transthoracic echocardiography in parasternal short 
axis view two hours after ICU admission. From this view, left 
ventricle end-diastolic diameter/end-systolic diameter = 56/46 
mm and ejection fraction 33% were measured.
Fig. 2. M-mode transthoracic echocardiography in parasternal short 
axis view 12 hours after ICU admission. From this view, left 
ventricle end-diastolic diameter/end-systolic diameter = 48/34 
mm and ejection fraction 59% were measured.
vine, CA, USA) was inserted via the right jugular vein and 
connected to an analysis system (VigilanceTM, Edwards Life-
sciences LLC, Irvine, CA, USA). The patient’s cardiac index 
was 3.5 L/min/m2 with mixed venous oxygen saturation of 
79%. An initial electrocardiogram upon arrival at the ICU 
showed normal sinus rhythm at 85 bpm. Chest X-ray, chemi-
stry, complete blood count, and urinalysis did not show any 
particular abnormalities.
  Two hours after ICU admission, the patient presented with a 
blood pressure of 117/81 mmHg, heart rate of 82 bpm, central 
venous pressure of 9 mmHg, cardiac index of 3.4 L/min/m2, 
and rectal temperature of 35.1oC. Transthoracic echocardio-
graphy revealed a slightly enlarged left ventricle (end-diastolic 
diameter (EDD)/end-systolic diameter (ESD) = 56/46 mm) and 
severe global hypokinesia of the left ventricle (Fig. 1). The 
left ventricular ejection fraction (LVEF) was measured at 33% 
by m-mode. Diastolic function could not be measured due to 
summation of mitral inflow waves from tachycardia. Valvular 
abnormalities were not observed except trivial mitral and tri-
cuspid regurgitation. Right ventricular systolic pressure mea-
sured from maximal tricuspid regurgitation jet velocity was 
within normal limits. Stress-induced cardiomyopathy was pre-
sumed considering the patient’s medical history, lack of myo-
cardial ischemia evidence by electrocardiogram, and normal car-
diac enzymes. We started dobutamine at 2μg/kg/min and a mix-
ture of insulin, glucose and potassium (regular insulin 325 unit 
＋ potassium chloride 80 mEq in 50% dextrose water 500 ml) 
at 10 ml/hr. Intravenous methylprednisolone sodium succinate 
(Solu-medrol, Pfizer Pharm., Seoul, Korea) 250 mg and levo-
thyroxine sodium (Synthyroid, Bukwang Pharm., Seoul, Korea) 
50μg was administered by nasogastric tube despite the fact 
that the results of thyroid function tests were not available at 
that time. Two serial clinical testing sets for brain reflexes 
were performed, including an apnea test, which showed ab-
sence of all cranial nerve function. The electroencephalogram 
demonstrated extremely low amplitude background activity with-
out any physiological variability or regional activities, compati-
ble with brain death. Vital signs were maintained stable and 
cardiac index was measured from 3.4−5.3 L/min/m2. Mixed 
venous oxygen saturation ranged from 79−91%.
  Twelve hours after ICU admission, the patient presented 
with a blood pressure of 136/94 mmHg, heart rate of 97 bpm, 
central venous pressure of 3 mmHg, cardiac index of 3.9 
L/min/m2, and rectal temperature of 35.9oC. Compared to the 
previous echocardiography results, left ventricular size was de-
creased to EDD/ESD = 46/33 mm and the previously observed 
severe hypokinesia of the left ventricle was no longer seen 
(Fig. 2). LVEF was improved to 59%. Diastolic function was 
still unmeasureable. Pulsed wave Doppler measured at the left 
ventricular outflow tract, which reflects stroke volume, was im-
proved from 9.6 cm to 12.2 cm. The family, intensivists and 
surgeons agreed to donate the patient’s heart.
  The donated heart was transported to another university hos-
pital to be transplanted into a patient with dilated cardiomyo-
pathy. Echocardiography performed 20 days after the transplan-
tation showed normal left ventricular systolic function (EDD/ESD 
= 48/34 mm, LVEF = 62%). There was no regional wall mo-
tion abnormality and mitral inflow showed normal pattern (E = 
98 cm/s, A = 31 cm/s, E/E’ = 14). Grade I mitral and tricus-
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pid regurgitation was noted. Myocardial biopsy demonstrated 
no evidence of rejection and coronary angiogram was normal.
DISCUSSION
  Despite marked improvements in medical or surgical inter-
ventions, heart transplantation often has been the only available 
and curative treatment modality for end stage heart failure 
patients. However, the major limitation of heart transplantation 
is donor heart shortage. Two approaches can be considered for 
settling this shortage issue. One is to adopt aggressive manage-
ment for cadaveric donors to increase the quantity of available 
organs, and the other is to recruit marginal hearts such as 
those from aged donors, with minimal coronary artery disease, 
requiring high doses of inotropes or showing acute systolic 
dysfunction induced by stress.5,6)
  Cardiovascular instability is very common in brain death.7) 
Hypotension is more common in hypovolemic donors treated 
with vasopressors and in patients with diabetes insipidus who 
do not receive antidiuretic hormone.8) The goals of manage-
ment of the hemodynamic status of the donor are to achieve 
normovolemia, maintain blood pressure, and optimize cardiac 
output so as to achieve gradients of perfusion pressure and 
blood flow that promote organ function with the use of the 
least amount of vasoactive-drug support.5)
  Brain injury can induce myocardial dysfunction, which is 
evidenced by many clinical and experimental reports.1-4) This 
change is known to be caused by two mechanisms: micro-
vascular spasm of coronary arteries induced by sympathetic ac-
tivation, and direct cardiotoxicity of catecholamines.9) This de-
rangement of cardiac function in brain injury is reversible, but 
the proportion of stunned myocardium is important for trans-
plant success. Stress tests can play a role in identifying the 
amount of hibernated myocardium. In a prospective study, se-
ven brain dead patients whose fractional shortening was under 
30% underwent dobutamine stress echocardiography and three 
of them demonstrated improvement of wall motion abnormali-
ties, whereas four of them did not.10) Those with reversible 
stress test results had normal troponin levels and gradual im-
provement by seven days after brain death; their clinical cour-
ses were similar to that of our patient.
  It is reasonable for us to consider that increased intracranial 
pressure along with high doses of vasopressors administered in 
the primary hospital contributed to the development of stress- 
induced cardiomyopathy in this patient. On arrival at our ICU, 
he was on high doses of dopamine, dobutamine, and epine-
phrine. Several studies recommend low dose vasopressin as the 
first line vasoactive drug for brain death patients.11-13) We per-
formed echocardiography evaluation only two hours after stop-
ping the high-dose vasoactive drugs. Therefore, we reasonably 
doubt that the remaining effects of vasopressor overdose may 
have been the cause of stress-induced cardiomyopathy.
  Appropriate management of cadaveric organ donors can re-
cruit organs in marginal ranges. Two retrospective studies re-
ported that thyroid hormone replacement in hemodynamically 
unstable patients can increase the number of available or-
gans.14,15) Another study suggested that aggressive management 
of brain dead patients with fluids, steroids, insulin and levo-
thyroxine may improve the quality and quantity of organs avail-
able for transplantation by decreasing vasopressor requirements 
and preventing cardiovascular collapse.16) The Canadian Critical 
Care Society recommended combined hormone therapy (thyroid 
hormone, vasopressin, and methylprednisolone) for hemodynami-
cally unstable patients or those with reduced EF under 40% 
demonstrated by 2D echocardiography.13) Hormone replacement 
also improved one month post graft survival in heart transplant 
patients.17)
  Another pharmacologic intervention for acute heart failure in 
brain dead patients is glucose-insulin-potassium mixture, or GIK 
solution.18) Dobutamine can disrupt the myocardial oxygen de-
mand-supply balance by inducing tachycardia and hypotension 
which may aggravate myocardial ischemia. However, GIK is 
known to be as efficient as dobutamine in improving heart 
function in cadaveric donors without causing tachycardia or hy-
potension, although only one heart has been actually donated.18)
  Two management protocols recommend combined hormone 
therapy (thyroid hormone, methylprednisolone, vasopressin, in-
sulin) in heart donors with LVEF ＜45%.5,6) In our patient, 
initial LVEF was measured at 33%. After combined hormone 
therapy, LVEF was improved to 59%. Using a combined ap-
proach of hemodynamic and metabolic management could re-
sult in a expansion of donor pool.
  In conclusion, we report a case of heart function restored by 
combining aggressive hemodynamic management with low dose 
dobutamine, GIK, and hormone. Further study is needed to de-
termine the outcome of donated hearts which show reversible 
heart dysfunction.
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